SPYH.DE vs. ETLI.DE
SPYH.DE (SPDR MSCI Europe Health Care UCITS ETF) and ETLI.DE (L&G Pharma Breakthrough UCITS ETF) are both Health & Biotech Equities funds - SPYH.DE tracks the MSCI Europe Health Care 20/35 Capped while ETLI.DE tracks the Solactive Pharma Breakthrough Value. Both are passively managed. Over the past 5 years, SPYH.DE returned 5.81%/yr vs 2.31%/yr for ETLI.DE. A 0.59 correlation means they provide meaningful diversification when combined. SPYH.DE charges 0.18%/yr vs 0.49%/yr for ETLI.DE.
Performance
SPYH.DE vs. ETLI.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SPYH.DE achieves a -1.97% return, which is significantly lower than ETLI.DE's -0.74% return.
SPYH.DE
- 1D
- 3.34%
- 1M
- 0.41%
- YTD
- -1.97%
- 6M
- -0.47%
- 1Y
- 6.02%
- 3Y*
- 2.85%
- 5Y*
- 5.81%
- 10Y*
- 6.16%
ETLI.DE
- 1D
- 2.62%
- 1M
- -4.04%
- YTD
- -0.74%
- 6M
- -2.52%
- 1Y
- 22.46%
- 3Y*
- 2.83%
- 5Y*
- 2.31%
- 10Y*
- —
SPYH.DE vs. ETLI.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
SPYH.DE SPDR MSCI Europe Health Care UCITS ETF | -1.97% | 7.82% | 3.98% | 7.88% | -4.55% | 25.71% | -2.51% | 33.07% | 3.51% |
ETLI.DE L&G Pharma Breakthrough UCITS ETF | -0.74% | 22.23% | 0.42% | -12.64% | -2.91% | 4.98% | 15.37% | 17.53% | -4.78% |
Correlation
The correlation between SPYH.DE and ETLI.DE is 0.55, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.55 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.53 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.56 |
Correlation (All Time) Calculated using the full available price history since Feb 26, 2018 | 0.59 |
The correlation between SPYH.DE and ETLI.DE has been stable across timeframes, ranging from 0.53 to 0.59 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SPYH.DE vs. ETLI.DE — Risk / Return Rank
SPYH.DE
ETLI.DE
SPYH.DE vs. ETLI.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR MSCI Europe Health Care UCITS ETF (SPYH.DE) and L&G Pharma Breakthrough UCITS ETF (ETLI.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SPYH.DE | ETLI.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.79 | ||
| Sortino ratioReturn per unit of downside risk | -1.10 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 1.20 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | 0.50 | 2.40 | -1.90 |
| Martin ratioReturn relative to average drawdown | 1.10 | 6.79 | -5.69 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SPYH.DE | ETLI.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.37 | 1.16 | -0.79 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.36 | 0.13 | +0.23 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.39 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.22 | +0.20 |
Drawdowns
SPYH.DE vs. ETLI.DE - Drawdown Comparison
The maximum SPYH.DE drawdown since its inception was -26.62%, smaller than the maximum ETLI.DE drawdown of -30.83%. Use the drawdown chart below to compare losses from any high point for SPYH.DE and ETLI.DE.
Loading charts...
Drawdown Indicators
| SPYH.DE | ETLI.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.62% | -30.83% | +4.21% |
Max Drawdown (1Y)Largest decline over 1 year | -12.58% | -9.06% | -3.52% |
Max Drawdown (3Y)Largest decline over 3 years | -26.62% | -23.90% | -2.72% |
Max Drawdown (5Y)Largest decline over 5 years | -26.62% | -30.83% | +4.21% |
Max Drawdown (10Y)Largest decline over 10 years | -26.62% | — | — |
Current DrawdownCurrent decline from peak | -10.72% | -4.86% | -5.86% |
Average DrawdownAverage peak-to-trough decline | -8.61% | -10.22% | +1.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.73% | 3.21% | +2.52% |
Volatility
SPYH.DE vs. ETLI.DE - Volatility Comparison
The current volatility for SPDR MSCI Europe Health Care UCITS ETF (SPYH.DE) is 6.01%, while L&G Pharma Breakthrough UCITS ETF (ETLI.DE) has a volatility of 6.89%. This indicates that SPYH.DE experiences smaller price fluctuations and is considered to be less risky than ETLI.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SPYH.DE | ETLI.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.01% | 6.89% | -0.88% |
Volatility (6M)Calculated over the trailing 6-month period | 12.04% | 14.09% | -2.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.05% | 18.72% | -1.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.76% | 17.22% | -1.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.82% | 18.91% | -3.09% |
SPYH.DE vs. ETLI.DE - Expense Ratio Comparison
SPYH.DE has a 0.18% expense ratio, which is lower than ETLI.DE's 0.49% expense ratio.
Dividends
SPYH.DE vs. ETLI.DE - Dividend Comparison
Neither SPYH.DE nor ETLI.DE has paid dividends to shareholders.
Frequently Asked Questions
SPYH.DE and ETLI.DE have a correlation of 0.55, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, SPYH.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
SPYH.DE is cheaper with a 0.18% expense ratio, compared with 0.49% for ETLI.DE.
SPYH.DE tracks MSCI Europe Health Care 20/35 Capped, while ETLI.DE tracks Solactive Pharma Breakthrough Value. They also come from different issuers: State Street and Legal & General. Their fees differ too: 0.18% for SPYH.DE and 0.49% for ETLI.DE.
Find the right allocation for SPYH.DE and ETLI.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer